Phase 1 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- People who have signed an informed consent form agreeing to take part in the study
- People aged 19 years or older who are generally healthy (not patients being treated for a condition)
- People whose Body Mass Index (BMI) falls between 18.5 and 29.9, which is considered a normal to slightly overweight range
Who may not be able to join:
- People who have an existing health condition that has not been fully treated or resolved, where that condition might affect how the body processes or responds to the study medications
- People who have abnormal results from health checks such as blood pressure measurements, heart tracings (ECG), physical examinations, gynaecological examinations, or blood and other laboratory tests (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82 53-200-6351
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cmax,ss of Empagliflozin, Total Ezetimibe and Rosuvastatin; AUCtau,ss of Empagliflozin, Total Ezetimibe and Rosuvastatin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.